SCHEMBL9380728

SCHEMBL9380728

CCCCN(c1ccncc1N)N1CCC(CCC)(CCC)C1=O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9379716 0.88 CYP19A1 (0.32) CYP19A1
SCHEMBL9381321 0.78 MAPT (0.32) CYP19A1
SCHEMBL9381929 0.69 BCHE (0.41)
SCHEMBL9377512 0.67 SLC6A2 (0.34)
SCHEMBL9380733 0.67 AOC1 (0.32)
SCHEMBL26056119 0.67 AOC1 (0.38) CYP19A1
SCHEMBL8872029 0.65 SLC6A2 (0.33)
SCHEMBL9380737 0.65
SCHEMBL9206194 0.65 SLC6A2 (0.34)
SCHEMBL14216406 0.59 AOC1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0413191-B1 1-(Pyridinylamino)-2-pyrrolidinones, a process for their preparation and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1994-07-27 EP disclosed
EP-0413191-A1 1-(Pyridinylamino)-2-pyrrolidinones, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-02-20 EP disclosed
US-4994472-A Cognition activators HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-02-19 US disclosed